Literature DB >> 17124397

How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?

Paul Johnson1, Mary Rosewell, Martin A James.   

Abstract

BACKGROUND: Patients remain at high risk of vascular events after stroke, transient ischaemic attack or carotid endarterectomy. We studied how well this risk is addressed by the effective treatment of modifiable risk factors.
METHODS: A total of 198 consecutive attenders at a rapid access stroke clinic and 98 consecutive patients undergoing carotid endarterectomy were studied. Treatment of hypertension and hyperlipidaemia, smoking status and the use of antithrombotic therapy were assessed at baseline and 6 months later. The findings were compared with targets from the UK National Clinical Guidelines for Stroke.
RESULTS: Baseline and follow-up data were available on 284 patients. The rates of control of vascular risk factors improved only slightly during follow-up. Blood pressure was below target levels in only 69 (24%) at baseline and 79 (28%) at 6 months, and serum cholesterol was below target levels in only 55 (19%) at baseline and 63 (22%) at 6 months. At baseline, 55 (19%) were smokers, of whom 12 (22%) had quit at 6 months. Anticoagulant therapy was prescribed in 19 of 37 patients (51%) in atrial fibrillation at 6 months. Antiplatelet therapy was prescribed in 90% of patients in sinus rhythm.
CONCLUSIONS: Despite the identification of vascular risk factors at the time of clinic or surgery, 6 months later these risk factors remain poorly addressed. More effective methods of managing vascular risk in these patients are needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17124397     DOI: 10.1159/000097053

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  7 in total

1.  Ambulatory treatment gaps in patients with ischemic stroke or transient ischemic attack.

Authors:  Kari L Olson; Lisa J Lash; Thomas Delate; Michele Wood; Jon Rasmussen; Anne M Denham; John A Merenich
Journal:  Perm J       Date:  2013

2.  Knowledge of stroke risk factors among primary care patients with previous stroke or TIA: a questionnaire study.

Authors:  Andrzej Sloma; Lars G Backlund; Lars-Erik Strender; Ylva Skånér
Journal:  BMC Fam Pract       Date:  2010-06-15       Impact factor: 2.497

3.  Decoding cryptogenic cardioembolism.

Authors:  James F Meschia
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

4.  A randomised controlled pilot study of standardised counselling and cost-free pharmacotherapy for smoking cessation among stroke and TIA patients.

Authors:  Sophia Papadakis; Debbie Aitken; Sophia Gocan; Dana Riley; Mary Ann Laplante; Abha Bhatnagar-Bost; Donna Cousineau; Danielle Simpson; Rojiemiahd Edjoc; Andrew L Pipe; Mukul Sharma; Robert D Reid
Journal:  BMJ Open       Date:  2011-11-28       Impact factor: 2.692

5.  Prescription of blood pressure lowering treatment after intracerebral haemorrhage: Prospective, population-based cohort study.

Authors:  Karl Bonello; Amy Pk Nelson; Tom J Moullaali; Rustam Al-Shahi Salman
Journal:  Eur Stroke J       Date:  2020-12-03

6.  Antiplatelet therapy for transient ischemic attack.

Authors:  Maria Czarina Acelajado; Suzanne Oparil
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-04       Impact factor: 3.738

7.  Blood pressure after follow-up in a stroke prevention clinic.

Authors:  Agnete Hviid Hornnes; Mai Bang Poulsen
Journal:  Brain Behav       Date:  2020-06-12       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.